Accel Research Sites recruiting for multiple RSV clinical trials

Create a Profile

First Name(Required)

Last Name(Required)

Location Preference(Required)

Phone*(Required)

Email Address*(Required)

Gender

Conditions*(Required)

Race / Ethnicity

Contact Preferences(Required)

I accept digital forms of communication(Required)

I confirm that (1) the name and contact information set forth above is my name and contact information or that I am submitting the form on behalf of an individual who has legally authorized me to submit this request; (2) the personal information I provide in this form may be used by Accel Research Sites, and its affiliates, partners, and medical professionals in connection with considering my potential participation in clinical research studies; (3) I am requesting that Accel Research Sites contact me using the information I have provided on Accel Research Sites’ website; and (4) I have read and understand Accel Research Sites’ Privacy Policy.

CAPTCHA

Hidden

UTM Source

Hidden

UTM Campaign

Name

This field is for validation purposes and should be left unchanged.

Create a Profile

First Name(Required)

Last Name(Required)

Location Preference*(Required)

Phone*(Required)

Email Address*(Required)

Gender

Conditions of Interest*(Required)

Race / Ethnicity

Contact Preferences*(Required)

I accept digital forms of communication(Required)

CAPTCHA

Hidden

UTM Source

Hidden

UTM Campaign

Comments

This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

Name(Required)

Last Name(Required)

Phone

Email(Required)

Reason for Contact(Required)

Enter additional message or questions(Required)

I accept digital forms of communication(Required)

I confirm that the name and contact information set forth above is my name and contact information or that I am submitting the form on behalf of an individual who has legally authorized me to submit this request; (2) the personal information I provide in this form may be used by Accel Research Sites, and its affiliates, partners, and medical professionals in connection with considering my potential participation in clinical research studies; (3) I am requesting that Accel Research Sites contact me using the information I have provided on Accel Research Sites’ website; and (4) I have read and understand Accel Research Sites’ Privacy Policy.

CAPTCHA

Phone

This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

-- or --

Select City No location found for this Location

FIND A TRIAL NEAR YOU

-- or --

Select City No location found for this Location

Back

Date Published: 02/16/2022

Accel Research Sites recruiting for multiple RSV clinical trials

While the world celebrates the development of COVID-19 vaccines, another vaccine breakthrough is waiting in the wings.

Six Accel Research Sites in Florida, Georgia and Alabama will be part of it.

Accel Research Sites is currently enrolling for multiple trials for vaccine candidates against Respiratory Syncytial Virus, or RSV.

RSV is a respiratory virus that can be deadly for infants and adults 60 or older. Researchers have been working on these important vaccines for years to help prevent illness in these vulnerable populations. Now, several vaccines are in the final trial stages, and approvals could be close at hand.

“RSV can be a big threat to the older population,” said Lora Parahovnik, CEO of Accel Research Sites. “It’s exciting that we’re at a point when multiple vaccines are being seriously considered for approval. We hope participants will be motivated to be part of this progress and potentially take advantage of the latest medical advancements for their own health.”

Accel and research sites across the country are seeking participants 60 and older to help move medicine forward. The company is recruiting for sites in DeLand, Lakeland, Maitland and St. Petersburg in Florida, as well as in Birmingham, Alabama and Lake Oconee, Georgia.

Principal investigators are Dr. Bruce Rankin, Dr. James Andersen, Dr. Eva-Maria Heurich, Dr. Gigi Lefebvre, Dr. Hayes Williams and Dr. Nicolas Chronos. Trials are enrolling mid-February through the end of March.

Those interested in participating should click here and a member of the Accel team will reach out to determine eligibility.

Back

Articles